Site Map

Member login

New AML genes discovered

2017 Clinical Excellence Awards Round

Applications open to become the next BSH Student Representative

Participate in the national Blood Transfusion and Blood Donation Survey

RCP publish Future Hospital Programme report

Applications invited for the position of Editor-in-Chief British Journal of Haematology

Register now and save up to £150

Abstract submissions for the BSH Annual Scientific Meeting 2018

A HaemSTAR is born

Survey reveals current UK practice of managing Hodgkin’s lymphoma in older patients

Applications open for L'Oreal-UNESCO Women in Science Awards

Digital digest

Ibrutinib non-responders may benefit from combination therapy for CLL

Digital digest - 2 February

HSF1 blockers promising for multiple myeloma

DNA repair and packaging genes linked to multiple myeloma risk

BSH Blood Transfusion Guidelines used in NBTC Blood Components App

Digital digest - 9 February

Ageing immune system ‘key to cancer development risk’

Hybrid-capture sequencing backed for lymphoid cancer

Digital digest - 16 February

Latest radiotherapy device will fine-tune bone marrow irradiation

BSH member Dr Amit Sud awarded haematology research medal

Progress predicted in haemoglobin disorder care

Landmark CAR T-cell study results published

Warning over anticoagulant use for atrial fibrillation in CKD

Digital digest - 23 February

Imaging tools reveals inner structure of red blood cells

Celebrating Success: BSH member part of haematology department awarded Myeloma UK service award

Promise for novel treatment in severe bleeding disorder

Digital Digest - 2 March

Age does not affect NHL survival after HCT

STAT5 inhibitor could target oncogenic pathway in leukaemia

Increased heart failure risk for breast cancer and lymphoma patients

Mixed-phenotype acute leukaemia patients benefit from less toxic therapy

International women's day 2018: Meet some of our women members making a difference in haematology

Digital Digest - 20 April

Former BSH President Allan Victor Hoffbrand wins Sultan Bin Khalifa International Thalassemia Grand International Award

Cardiovascular risks faced by child cancer survivors

Clue to future ALL relapse

Headway in development of lymphoma epigenetics therapeutics

BSH becomes sponsor and partner of Health Volunteers Overseas

Stored blood ‘less safe’ for some patients

Warning as blood stocks stay low

BSH announces Professor Simon Rule as new Vice President

Scientists get stem cells through... the snow

Rare disease patients need Europe - MPs

Applications are now open for NHS England’s Clinical Entrepreneurs Programme

New therapeutic targets for aggressive diffuse large B-cell lymphoma

Warfarin alternatives effective for catheter ablation

Anaemia risks maternal death

Applications open for Chief Scientific Officer's Knowledge Transfer Partnership programme for leaders in healthcare science

Annual Scientific Meeting - Join the social media campaign

New VTE prevention guidance for over-16s

Professor John Barrett MD appointed as Editor-in-Chief of British Journal of Haematology

Genetic variation and biomarkers may help predict brain injury risk in paediatric ALL

Gene fusion an early event in childhood leukaemia

Chronic graft-versus-host disease gene regulation insight

‘Organic gene therapy’ approach suggested for red cell disorders

New cancer drug class unveiled at Imperial

Genetic alterations in multiple myeloma revealed

Novel epigenetic link to blood cancer

NHS genomics project “at risk” - MPs

BSH announces Professor Cheng-Hock Toh as President

Special Resolution to adopt updated articles

Digital Digest - 11 May

Bloodwise Highlights from the BSH Annual Scientific Meeting 2018

NHS preparing to offer CAR-T therapy to patients

‘Young, Black and Stigmatised’ - Dr Sonia Wolf wins inaugural Crucible Prize

Progress towards universal red cell source

Meta-analysis reveals best treatments for post-partum haemorrhage

The Aplastic Anaemia Trust are inviting grant applications as they launch new research strategy

Genetic profiling of blood samples could help personalise multiple myeloma treatment

Genomic analysis could help patients with DLBCL

Type O blood ‘increases risk of death from trauma’

World Thalassaemia Day – Time of new hope?

BSH celebrating International Nurses Day 2018

Introducing Professor Cheng-Hock Toh - BSH President's first message

Step towards biomarker that predicts CAR T cell therapy response

Senior haematologists have called on NHS England to reverse restrictions on using ibrutinib to treat relapsed chronic lymphocytic leukaemia

CPD budget cuts affecting nursing skills - Royal College of Nursing

Tablet hope for cancer-related VTE

Genome sequencing allows improved blood transfusion matching

Inflammatory signalling protein plays key role in AML

Haemophilia survey highlights fears

ALL gene-environment interaction points to hygiene factor

How haemophilia nursing care is evolving

European trial of new leukaemia drug pairing

Reprogrammed cells could correct haemophilia B

Genomic atlas of human plasma proteome unveiled

BSH celebrate World Blood Donor Day 2018

Chief Executive of the Sickle Cell Society is awarded an OBE in the Queen’s Birthday Honours.

Bone marrow recreated in lab

Gene editing of healthy cells offers prospect for CAR T treatment of AML

World Sickle Cell Day - Dr Sonia Wolf Q&A

What is Sickle Cell Disease (SCD)?

Football key to blood donor recruitment

New target to fight Fanconi anaemia

GP urgent cancer referrals increase sharply

Message from BSH President

Lymphoma risk from myelofibrosis treatment

Blood cancer therapy toxicity examined

New drugs are improving survival times for patients with aggressive type of blood cancer

BSH Celebrating 70 years of the NHS

Sepsis research targets vascular leakage

New drugs improve MCL patient survival times

Leukaemia virus changes DNA packaging

DOACs a safe alternative to warfarin

EMA approves CAR T-cell therapies in milestone decision

Former BSH President Dr Patrick Carrington interviewed on BBC 5 Live for NHS 70th Anniversary

Contaminated blood inquiry truth promise

Gene therapy hope for Hunter syndrome

Genetic changes in blood predict AML risk

Biomedical science day 2018 - Meet BSH Member Dr Maria Teresa Esposito

AML cell study offers clues to super-drug improvement

Off-target effects dash gene editing hopes

Genetics of Xga blood group system uncovered

Urine test useful for monoclonal gammopathy

A message from BSH President, Professor Cheng-Hock Toh

BSH President Professor Cheng-Hock Toh elected as Academic Vice President of the RCP

Blood cancers taking longer to be diagnosed than other cancers

Study informs on monosomy 7 genetics

Fertility risk for sickle cell and chemotherapy patients

Knife crime surge draws on blood stocks

Urgent appeal for Ro blood donors

BSH expanding Early Stage Research Start-Up programme

Leukaemia patients spared repeat chemotherapy following NHS review

Shot Report 2017 published

Obituary - Dr S. Mitchell Lewis

Former BSH President Dr Victor Hoffbrand receives Wallace H. Coulter Award for Lifetime Achievement in Haematology

Computational platform developed for multiple myeloma treatment

Simple blood test could detect Multiple Myeloma

Novel targets for mixed lineage leukaemia

Patients perplexed by blood cancer diagnosis

Brexit blood product plans revealed

Tributes to campaigner who became nurse

Blood cancer patients could be denied life-saving CAR-T therapy

A message from BSH President, Professor Cheng-Hock Toh - August 2018

Blood cancer awareness - Meet BSH Member Graham Collins

Celebrating NHS 70 and Haematology

Blood test predicts lymphoma therapy success

Enzymes may enable type O blood transformation

CAR-T backed for NHS

“Achilles’ heel” of anaplastic large-cell lymphoma identified

Study discovers ten times more haematopoietic stem cells than previously thought

Study reveals the impact on the brain of chemotherapy for acute lymphoblastic leukaemia

Comment: Dr Maria Esposito on NHS decision to approve use of CAR T therapy

AI to improve platelet supply

Genomics focus: Meet BSH Member David Rees

European collaboration for cancer research

CAR-T therapy provisionally rejected for adult B-cell lymphoma

Office Closure & Temporary Office Move

ASM 2019: Call for abstract reviewers

Changes to BSH Membership from 2019

Immediate compression may reduce risk of long-term DVT complications

A message from BSH President, Professor Cheng-Hock Toh - September 2018

Paediatric radiotherapy guidance updated for new technologies

Lung cancer drugs studied for leukaemia treatment

BSH Student Essay Prize 2018

Inquiry searches for undiagnosed blood contamination victims

Apply for the 2019 Healthcare Science Awards

Dan's Story: BSH member inspires patient to follow career in medicine

CAR-T deal allows adult lymphoma treatment

May’s SOS for cancer care

Leukaemia UK launch 'Future of Haematology' Grants Programme

Hope for fewer blood transfusions for myelodysplasia care

World Thrombosis Day 2018 - Message from BSH President Professor Cheng-Hock Toh

World Thrombosis Day: Meet BSH Member & Thrombosis expert Professor Beverley Hunt

World Thrombosis Day: Thrombosis UK offer range of resources, grants and educational opportunities

New prognostic tool provides “step change” in myeloproliferative neoplasm care

Blood and organ donors from black communities needed

Genetics-based prognostic tool developed for myelodysplastic syndrome

NIHR-BSH Researcher of the Year Award scheme 2019

Massive new AML dataset published

BSH & Wiley renew partnership to publish British Journal of Haematology

New technique revealed to help blood cells regenerate

A message from BSH President, Professor Cheng-Hock Toh - October 2018

Duvelisib hope for hard-to-treat CLL and SLL

BSH Crucible Prize: Feature with 2018 winner Dr Sonia Wolf

‘Rethink’ needed for classification of VTE

Relapsed AML returns in ‘stealth mode’

National Pathology Week - Meet BSH Member Dr Sheila O'Connor

Low-fat diet might benefit obese children with ALL

Denosumab effective for osteoporosis in transfusion-dependent thalassaemia

Chemotherapy and immunotherapy success in AML study

Top 10 research priorities for living with and beyond cancer announced

AML gene study brings personalised medicine one step closer

Discount deal makes CAR-T available to young leukaemia patients

Multiple myeloma drug hope

A message from BSH President, Professor Cheng-Hock Toh - November 2018

‘Universal plasma’ filtration plans unveiled

SCID study identifies factors influencing survival

BSH to offer EHA Travel Grants

CRISPR therapy feasible for foetal haemoglobin reactivation

BSH Communications Committee Vacancy

Fred Hutchinson researchers present latest on CAR-T cell therapy at ASH 2018

Chance discovery could revolutionise platelet donations

Paediatric CAR-T therapy begins in England

BSH President Professor Cheng Hock Toh pays tribute to outgoing Editor of BJHaem, Professor Finbarr Cotter

Sickle cell gene therapy success

New tool to identify aggressive lymphomas

Differences between paediatric and adult AML uncovered

CAR T-cell therapy approved for more NHS treatment

CRISPR accuracy breakthrough

A message from BSH President, Professor Cheng-Hock Toh - December 2018

Obituary - Professor Sir David Weatherall

Lenalidomide extends remission in newly-diagnosed myeloma

Eye drop treatment offers AML hope

Human skin cells turned into blood stem cells

First European CAR T cell meeting announced

Boosted cord blood aids transplant

Haematology Nursing: Meet BSH Member Bethan Ingram

AZD8055 promise for CLL combination treatment

Comments needed for ASH VTE Guideline Treatment of Acute VTE

NHS plan offers new hope for blood cancer care

Blood screening for Zika ‘not cost‑effective’

CRISPR gene editing library identifies new immune regulators

Infected Blood Inquiry

Venetoclax fast-tracked into NHS for CLL

Ibrutinib effective for CLL therapy

New genetic classification of B-ALL

‘Twin genes’ behind B-cell disease are not identical

World Thrombosis Day Campaign Appoints BSH member Beverley Hunt as New Steering Committee Chair

A message from BSH President, Professor Cheng-Hock Toh - January 2019

Delays in blood cancer diagnosis could be avoided, Yorkshire study finds

No benefit from transplantation in hypodiploid ALL for children and young people, study finds

Leukaemia causes bone marrow cells to age prematurely

NICE recommends new CAR-T cell therapy for DLBCL

BSH grant recipient has work published in Oncogene

Tissue homing of T cells revealed

Hope for new drugs for relapsed AML

CAR‑T therapy rejected for DLBCL in Scotland

Antibody could prepare for stem cell transplant

Sickle cell silent strokes studied

Obituary - Dr Bryon Roberts (1933 - 2019)

Vitamin D and immune cells stimulate myelofibrosis in MPN

BSH gathering UK Clinical Haematology Workforce data

BSH partnering with HVO to offer short term overseas placements for UK Haematologists

BSH and Wiley partner on a peer-reviewed open access journal

A message from BSH President, Professor Cheng-Hock Toh - February 2019

‘Invisible’ stem cells offer new transplant prospects

Roger Counter Foundation to support BSH Research Grants

Role of free radicals in blood clotting revealed

Patient involvement partnership sets priorities for rare inherited anaemias

Thromboprophylaxis study shows limited benefits for cancer patients

Telomere test for CLL

International women's day 2019: Meet some of our women members making a difference in haematology

Second patient achieves full HIV remission after stem cell therapy

Vitamin analogue may boost stem cell transplant

AML cell type atlas created

Daratumumab combination therapy approved for relapsed multiple myeloma

Half-matched transplant success for sickle cell and thalassaemia

Two-minute test to assess platelet function developed

BSH Ordinary Trustee election results

Contradictory role for protein in AML uncovered

BSH Annual Scientific Meeting 2019 - Join the social media campaign

A message from BSH President, Professor Cheng-Hock Toh - March 2019

Chronic oncologist shortages revealed

New study reveals how mistakes in antibody production may trigger ALL

General Haem Task Force Vacancy

Deformable blood stem cells could help transplant procedures

Drug combination gives hope to older AML patients

Surprising role for protein in GvHD

Live imaging shows CAR-T therapy killing lymphoma cells

New sub groups of acute erythroid leukaemia defined

Gilteritinib improves FLT3-mutated AML survival

Successful gene therapy for SCID in infants

Cancer genetic vulnerabilities revealed on a large scale using CAS-9 knock out screens

Prophylactic Factor VIIa therapy tested for haemophilia

Old diabetes drug shows promise for preventing lymphoma

Professor Victor Hoffbrand receives BSH Lifetime Achievement Award

New promising target for AML discovered

Gene therapy may outperform stem cell transplant for beta-thalassaemia

Grant Impact report: Dr Yeong Jer Lim, ASH Travel Scholarship, 2018

High-risk multiple myeloma DNA marker identified

Grant Impact report: Dr George Adams, ASH Travel Scholarship, 2018

New study paves the way for B cell therapy

Single-cell analysis of bone marrow microenvironment cells completed

Spliceosome could hold key to stopping AML progression

‘Powerful’ APL drug combination could benefit AML patients

New drug can tackle ibrutinib resistance in MCL patients

Experts call for SCD screening for migrants in Europe

New molecule driving Hodgkin’s lymphoma growth discovered

Grant Impact report: Katie Parrott, Student Elective Scholarship 2018

Genetic variations may affect sickle cell trait athletes’ risk of collapse

Meet Huw Rowswell - NIHR / BSH Nursing Award Winner

Lenolidomide approved by NICE for treatment of multiple myeloma

A message from BSH President, Professor Cheng-Hock Toh - May 2019

Neurotoxic side-effects of CAR T-cell therapy revealed

Wnt signalling study brings lab-made stem cells closer

New culture technique could increase access to stem cell transplants

New target for B-cell lymphoma identified

'Antimicrobial resistance: Biting the hand that feeds' - Dr Jennifer Darlow wins Crucible Prize

New avenue for targeted therapy for T-cell leukaemia

Measuring walking speed aids prognosis of elderly cancer patients

Triple therapy boosts B-cell lymphoma treatment

New haemophilia gene therapy to help young patients

Grant Impact report: Thea Chandler, Student Elective Scholarship 2018

Grant Impact report: Eilish McKenna, Student Elective Scholarship 2018

Sickle Cell Disease in Childhood: Standards for Clinical Care Consultation

Pregnancy history of blood donors does not affect recipient mortality risk

World Sickle Cell Day 2019 - Dr Banu Kaya explains the advances made in the understanding and treatment of SCD

Hope for non-invasive prenatal sickle test

AML researcher receives Cancer Research UK fellowship grant

NHS prepares for new generation of ‘agnostic’ cancer drugs

Promising early results for novel sickle cell drug

BSH Global Haem SIG seeking Task Force volunteer for Plenary Speaker Scheme

Stress-responsive protein’s role in CML revealed

A message from BSH President, Professor Cheng-Hock Toh - June 2019

Myeloma leads the way in cancer survival improvements

Bleeding and thromboembolic risks for blood cancer patients estimated

Immunotherapy hope for paediatric ALL treatment

Dasatinib ‘pauses’ CAR T cell therapy activity

Depression linked to early death in blood cancer patients

Down's syndrome leukaemia genes pinpointed

Rise predicted in B-cell non-Hodgkin’s lymphoma cases

CAR-T cell therapy ‘super-charged’ for solid tumours

Cure Leukaemia Announce 12 Funded Centres Across The UK

Rise expected in haemophilia A and B market

Leukaemia stem cell study reveals cause of immune evasion

Effects of iron status on health studied

Physician Associate Focus - Meet BSH Member Jamie Saunders

BRCA2 mutations linked to childhood lymphoma

A message from BSH President, Professor Cheng-Hock Toh - July 2019

Antibiotics could be used to treat CTCL

New drug target identified for primary effusion lymphoma

Combination therapy shows early success in CLL trial

BSH/NHSE Acute Oncology Services Survey

Hope for new lymphoma ‘immunotransplant’ therapy approach

Mature AML cells can regain stem cell properties

Combination therapy for treatment-resistant ALL studied

Newly launched Haematology Podcast sees early success

Link between anaemia and necrotising enterocolitis studied

Guidelines Session ASM videos available for viewing

BSH seeks Consultant to join Communications Committee

New gene editing technique tested in lymphoma cells

Global Haematology SIG London Workshop

BSH seeks volunteer Chair for Genomics Working Group

NIHR-BSH Researcher of the Year Award

Access to haemophilia drug emicizumab widened

A message from BSH President, Professor Cheng-Hock Toh - August 2019

BSH Rebuttal to NICE NG89 Recommendations

Selinexor shows promise for refractory multiple myeloma

Red blood cell line may revolutionise malaria research

AML drug may be key to cancer immunotherapy

Heart risk after childhood cancer studied

New guidelines on rare aggressive T-PLL

Concern about blood cancer diagnosis progress

Use of haematopoietic stem cell transplantation for sickle cell disease for adults.

NHS England Evidence review: Comments needed on for delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies

Three times more men with haemophilia than previously thought

Genomics Focus: Meet Dr Suthesh Sivapalaratnam

New potential targets for lymphoma treatment discovered

Radiotherapy could help prevent CAR-T cell therapy side effects

Scientists discover how lymphoma cells metastasise to the CNS

Arthritis drug could reduce MPN symptoms

Gene test reveals new option for JMML

A message from BSH President, Professor Cheng-Hock Toh - September 2019

Familial risk of blood cancers analysed

BSH Global Haematology SIG: We are looking for a Lab Scientist and Paediatric Haematologist for one week trip to Zambia

Laser technology cuts blood incubation time

Few sickle cell trials cross borders

New combination treatment suggested for AML

Hypertension warning for ibrutinib

Research starts on preventing cognitive decline in paediatric ALL patients

Debate rages over human germline editing

Studies highlight RNA splicing faults in cancer formation

Viagra potential for bone marrow mobilisation

Charity calls for an end to delays in blood cancer diagnosis

Collaboration to boost care of childhood cancer in developing world

Professor Andrew M. Evens appointed as Editor-in-Chief of British Society for Haematology (BSH)’s new Open Access journal eJHaem

Link between cognitive problems and fitness for ALL survivors

Improvements to cancer immunotherapy unveiled

Plant compound could improve gene therapy

‘Prime editing’ system could efficiently correct DNA in human cells

A message from BSH President, Professor Cheng-Hock Toh - October 2019

Board of Trustee Nominations

Hospital visit patterns could identify potential myeloma risk

Treating ‘smouldering’ multiple myeloma delays progression

Trial reduces central nervous system relapse in ALL

New wave of embryonic haematopoiesis discovered

Antibiotics could overcome venetoclax resistance in AML

CRISPR-edited immune cells for cancer tested in Phase I trial

ASH-BSH Abstract Achievement Award winners announced

BSH President's November message

Immunotherapy study identifies multiple myeloma neoantigens

Hydroxyurea may prevent cytarabine resistance in AML

Bone marrow transplant survival rate rises

Progress for Philadelphia chromosome ALL treatment

Join the Teenage and Young Adult Special Interest Group

A look at the complexities and challenges in Lymphoma and the work of the BSH Lymphoma SIG on World Cancer Day Feb 4th 2020

Cutaneous T-cell lymphoma origins revealed

Defect drives primary resistance to CAR-T cell therapy

Gene therapy success for X-CGD patients

International Day of Women & Girls in Science 2020: An Interview with Professor Adele Fielding

Single gene cluster loss associated with multiple myeloma

Aplastic Anaemia Awareness Day 2020

Blood Clot Awareness Month 2020: Blood Clot Management at University Hospitals Plymouth

International Women’s Day 2020 – Interview with Dr. Tamara Everington

COVID-19 Updates

BSH cancels 2020 Annual Scientific Meeting

Charity issues coronavirus guidance for blood cancer patients

Genes identify ‘ultra-high risk’ multiple myeloma

BSH and COVID-19

NIHR Appoints Dr Dan Hart as National Specialty Lead for Haematology

Professor Toh's 24th and final message to BSH: #bettertogether

Announcement of new trustees

Introducing Professor Adele Fielding - BSH Presidents first message

COVID 19 causes new clotting disorder – Dublin study

NHSBT - Understanding the convalescent plasma trials for COVID-19

A message from BSH President, Professor Adele Fielding - May 2020

Novel AML model offers new target

Child shielding rules relaxed - but not for some blood cancer patients

Obituary - Professor Dennis Wright

Trial results support use of early prophylaxis for childhood haemophilia A

A message from BSH President, Professor Adele Fielding - June 2020

Immune landscape of haematological cancers mapped

A message from BSH President, Professor Adele Fielding - July 2020

BSH Member Research – we need your help

TP53 allelic status predicts MDS outcomes, study finds

A message from BSH President, Professor Adele Fielding - August 2020

Medical marijuana for sickle cell patients means fewer hospitalisations

Guidelines on the use of irradiated blood components published on 18 August 2020

Blood transfusions could protect brain after stroke

A message from BSH President, Professor Adele Fielding - September 2020

Leukaemia nervous system “sanctuary” discovered

What is a virtual poster walk?

A message from BSH President, Professor Adele Fielding - October 2020

Blood group linked to COVID-19 risk

India trial finds limited effectiveness from convalescent plasma

New way to test drugs for children’s cancers

BSH Crucible Prize: Interview with 2020 winner Dr Joshua Bomsztyk

Board of Trustee Nominations 2020

A message from BSH President, Professor Adele Fielding - November 2020

Transplant proves beneficial for older myelodysplastic syndrome patients

No increased COVID-19 risk for children with cancer

COVID-19 thrombosis clarity to improve research

A message from BSH President, Professor Adele Fielding - December 2020

Myeloproliferative neoplasm mutations can occur decades before cancer develops

No benefit from increased haemoglobin threshold for very premature babies

Cord stem cell hope for severe COVID-19

On-off 'switches' to control CAR-T cell activity

Variation in cancer patient COVID-19 responses

New global clinical guidelines for von Willebrand Disease

Scientists identify possible therapeutic approach to overcome AML drug resistance

COVID-19 convalescent plasma collection halted after fresh setback

A message from BSH President, Professor Adele Fielding - January 2021

A message from BSH President, Professor Adele Fielding - February 2021

A message from BSH President, Professor Adele Fielding - March 2021

Cancer patients may need rapid COVID-19 vaccine booster, early study suggests

Single-cell genetic testing method identifies cancer stem cells

Whole genome sequencing role in guiding blood cancer treatment

Mechanism shared by sickle cell disease and malaria resistance revealed

Guidance produced by the Expert Haematology Panel (EHP) focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT)

Promising dual CAR-T therapy for B-cell lymphoma

New group launched to fund research into Covid-19 vaccine efficacy for blood cancer

A message from BSH President, Professor Adele Fielding - April 2021

Group of charities announce first blood cancer vaccine efficacy research funding

Charity collaborative announces investment of £800K in vaccine efficacy research

Keeping patients with leukaemia safe during the pandemic

Lockdown ending poses multiple risks for blood cancer patients

In memoriam Professor Amit Patel

BSH Board of Trustee elections are now open

BSH supports Strengthening workforce planning in the health and care bill: coalition principles

Election results 2022

BSH's response to the conflict in Ukraine

Study reveals new insights into lethal infant leukaemia

BSH Crucible Prize: Interview with 2022 winner Dr Richard Buka

New target and potential treatment for AML identified

BSH Presidential Message May 2022

Extra sex chromosomes increase clot risk in men

Blood clotting proteins linked to poor breast cancer outcomes

COVID vaccine boosters benefit blood cancer patients

New method to predict hyperdiploid B-ALL relapse risk

Metabolic profile identified in some AML patients

Second COVID booster advised for immunocompromised groups

ProMMise trial launched for relapsed myeloma

Mutations in healthy B-cells similar to cancerous ones

BSH is saddened by the death of Her Majesty, Queen Elizabeth II.

BSH response to the release of the AoMRC new report Fixing the NHS Why we must stop normalising the unacceptable

Update to Oral Anticoagulation Information and Monitoring Booklets (the “Yellow Book”)

Test News Item

Sickle cell report highlights continuing health inequalities

BSH Board of Trustee Nominations 2023

BSH Board of Trustee Nominations 2023 (1)

Test News Story

YH TEST - V1

Saskia test 7 December

Please work 2

YH test 2

National Clinical Impact Awards – Role of Member Organisations

COVID 19 causes new clotting disorder – Dublin study Test

YH test

This is a test news item - January 2024

A new news item for a new year

Jack's Test Article